当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Nehal Yemula, Vaclav Dostal, Michael Hornberger, Celina Dietrich
Background: Parkinson’s Disease (PD) is a progressive neurological condition characterized by degeneration of dopaminergic neurones within the basal ganglia. Accruing evidence from a variety of different studies suggests pathophysiological changes may first originate in the gut before they become apparent within the brain. The aim of the study was to investigate the prevalence of Gastrointestinal Tract symptoms (GIT) of early-stage PD patients. As such, this research aims to provide further supporting evidence to this limited field.
Methods: A single-center cross-sectional study conducted over 4 months which followed 12 participants with early-stage PD and 9 healthy controls. Participants completed a PD-specific gastrointestinal symptom questionnaire. Disease progression was evaluated through the Hoehn and Yahr Scale and Unified Parkinson’s Disease Rating part III (UPDRS) motor score.
Results: Tenesmus (83.3%), constipation (58.3%) and abdominal bloating (58.3%) were the most experienced symptoms for early-stage PD patients. Tenesmus (p=0.006) and constipation (p=0.03) also showed statistically significant differences between PD and control groups. However, there was no significant relationship between the prevalence of gut symptoms and UPDRS motor score (r=0.278, p=0.38).
Conclusion: A variety of gastrointestinal symptoms, particularly lower gastrointestinal tract, were prevalent in early-stage disease. There was no apparent relationship between the prevalence of gastrointestinal tract symptoms and the UPDRS motor score. A well designed, appropriate gastrointestinal tract questionnaire to screen for symptoms in early-stage disease may be of use in future clinical practice.